Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review

Immune checkpoint inhibitors (ICI) have revolutionized the management of locally advanced and advanced non-small lung cancer (NSCLC). With an improvement in the overall survival (OS) as both first- and second-line treatments, ICIs, and especially programmed-death 1 (PD-1) and programmed-death ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourbonne, Vincent, Geier, Margaux, Schick, Ulrike, Lucia, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219996/
https://www.ncbi.nlm.nih.gov/pubmed/35740259
http://dx.doi.org/10.3390/biomedicines10061237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219996/
https://www.ncbi.nlm.nih.gov/pubmed/35740259
http://dx.doi.org/10.3390/biomedicines10061237

Ejemplares similares